Meeder Asset Management’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Meeder Asset Management's VCYT Position: Q2 2026 in Review
Meeder Asset Management sold out of Veracyte (VCYT) in Q2 2026, closing a stake of 1,925 shares — an estimated $62K sold.
Meeder Asset Management first reported a position in VCYT in Q4 2016 and held it in 22 quarters. The position peaked at $2.43M in Q3 2022. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Meeder Asset Management reported no remaining Veracyte position as of Q2 2026 after selling out during the quarter.
- Meeder Asset Management sold 1,925 Veracyte shares in Q2 2026, an estimated $62K.
- Meeder Asset Management first reported a position in Veracyte in Q4 2016 and held it in 22 quarters.
- Meeder Asset Management's Veracyte position peaked at $2.43M in Q3 2022.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.